Europe Continuous Glucose Monitoring Device Market By Component (Sensors, Transmitters, and Receivers) By End User (Hospitals, Homecare Settings and Other End Users) By Country, Industry Analysis and Forecast, 2020 - 2026
The Europe Continuous Glucose Monitoring Device Market would witness market growth of 12% CAGR during the forecast period (2020-2026).
Continuous glucose monitors (CGMs) are widely available and efficient as a tool for real-time biofeedback and behavioral improvement for individuals with type 2 diabetes (T2D), and also those with prediabetes. A convergence of many megatrends in healthcare will lead to the ever more frequent use of CGM in people with T2D and even prediabetes. This will also further boost the precision, size, and cost of CGM; include the option to transfer data to the cloud. The integration will ensure the availability of digital coaching methods and computational applications, and eventually, artificial intelligence and a change to value-based treatment will follow.
Growing cases of diabetes have accelerated the market, along with the rising use of continuous glucose monitoring (CGM) devices. CGM devices are minimally invasive and provide a simple and reliable approach to diabetes treatment. They can also track dramatic changes in levels of blood glucose, thereby avoiding hypoglycemic disorders.
Through the assistance of a sensor, these instruments enable the analysis of blood glucose levels at different time intervals. Respective readings fed in via a wireless network to a diabetes treatment software allow patients to better understand the condition, thereby allowing them to treat it more effectively.
Based on Component, the market is segmented into Sensors, Transmitters, and Receivers. Based on End User, the market is segmented into Hospitals, Homecare Settings and Other End Users. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson
Scope of the Study
Market Segmentation:
By Component
Continuous glucose monitors (CGMs) are widely available and efficient as a tool for real-time biofeedback and behavioral improvement for individuals with type 2 diabetes (T2D), and also those with prediabetes. A convergence of many megatrends in healthcare will lead to the ever more frequent use of CGM in people with T2D and even prediabetes. This will also further boost the precision, size, and cost of CGM; include the option to transfer data to the cloud. The integration will ensure the availability of digital coaching methods and computational applications, and eventually, artificial intelligence and a change to value-based treatment will follow.
Growing cases of diabetes have accelerated the market, along with the rising use of continuous glucose monitoring (CGM) devices. CGM devices are minimally invasive and provide a simple and reliable approach to diabetes treatment. They can also track dramatic changes in levels of blood glucose, thereby avoiding hypoglycemic disorders.
Through the assistance of a sensor, these instruments enable the analysis of blood glucose levels at different time intervals. Respective readings fed in via a wireless network to a diabetes treatment software allow patients to better understand the condition, thereby allowing them to treat it more effectively.
Based on Component, the market is segmented into Sensors, Transmitters, and Receivers. Based on End User, the market is segmented into Hospitals, Homecare Settings and Other End Users. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson
Scope of the Study
Market Segmentation:
By Component
- Sensors
- Transmitters and
- Receivers
- Hospitals
- Homecare Settings and
- Other End Users
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Abbott Laboratories
- Medtronic PLC
- F. Hoffmann-La Roche Ltd.
- Novo Nordisk A/S
- DexCom, Inc.
- Ypsomed AG
- Senseonics Holdings, Inc.
- GlySens, Incorporated
- A. Menarini Diagnostics Ltd. (The Menarini Group)
- Echo Therapeutics, Inc.
- Johnson and Johnson
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Continuous Glucose Monitoring Device Market, by Component
1.4.2 Europe Continuous Glucose Monitoring Device Market, by End User
1.4.3 Europe Continuous Glucose Monitoring Device Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT
3.1 Europe Sensors Market by Country
3.2 Europe Transmitters Market by Country
3.3 Europe Receivers Market by Country
CHAPTER 4. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER
4.1 Europe Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 Europe Homecare Settings Market by Country
4.3 Europe Other End Users Market by Country
CHAPTER 5. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY
5.1 Germany Continuous Glucose Monitoring Device Market
5.1.1 Germany Continuous Glucose Monitoring Device Market by Component
5.1.2 Germany Continuous Glucose Monitoring Device Market by End-user
5.2 UK Continuous Glucose Monitoring Device Market
5.2.1 UK Continuous Glucose Monitoring Device Market by Component
5.2.2 UK Continuous Glucose Monitoring Device Market by End-user
5.3 France Continuous Glucose Monitoring Device Market
5.3.1 France Continuous Glucose Monitoring Device Market by Component
5.3.2 France Continuous Glucose Monitoring Device Market by End-user
5.4 Russia Continuous Glucose Monitoring Device Market
5.4.1 Russia Continuous Glucose Monitoring Device Market by Component
5.4.2 Russia Continuous Glucose Monitoring Device Market by End-user
5.5 Spain Continuous Glucose Monitoring Device Market
5.5.1 Spain Continuous Glucose Monitoring Device Market by Component
5.5.2 Spain Continuous Glucose Monitoring Device Market by End-user
5.6 Italy Continuous Glucose Monitoring Device Market
5.6.1 Italy Continuous Glucose Monitoring Device Market by Component
5.6.2 Italy Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of Europe Continuous Glucose Monitoring Device Market
5.7.1 Rest of Europe Continuous Glucose Monitoring Device Market by Component
5.7.2 Rest of Europe Continuous Glucose Monitoring Device Market by End-user
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Continuous Glucose Monitoring Device Market, by Component
1.4.2 Europe Continuous Glucose Monitoring Device Market, by End User
1.4.3 Europe Continuous Glucose Monitoring Device Market, by Geography
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT
3.1 Europe Sensors Market by Country
3.2 Europe Transmitters Market by Country
3.3 Europe Receivers Market by Country
CHAPTER 4. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER
4.1 Europe Hospitals Continuous Glucose Monitoring Device Market by Country
4.2 Europe Homecare Settings Market by Country
4.3 Europe Other End Users Market by Country
CHAPTER 5. EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY
5.1 Germany Continuous Glucose Monitoring Device Market
5.1.1 Germany Continuous Glucose Monitoring Device Market by Component
5.1.2 Germany Continuous Glucose Monitoring Device Market by End-user
5.2 UK Continuous Glucose Monitoring Device Market
5.2.1 UK Continuous Glucose Monitoring Device Market by Component
5.2.2 UK Continuous Glucose Monitoring Device Market by End-user
5.3 France Continuous Glucose Monitoring Device Market
5.3.1 France Continuous Glucose Monitoring Device Market by Component
5.3.2 France Continuous Glucose Monitoring Device Market by End-user
5.4 Russia Continuous Glucose Monitoring Device Market
5.4.1 Russia Continuous Glucose Monitoring Device Market by Component
5.4.2 Russia Continuous Glucose Monitoring Device Market by End-user
5.5 Spain Continuous Glucose Monitoring Device Market
5.5.1 Spain Continuous Glucose Monitoring Device Market by Component
5.5.2 Spain Continuous Glucose Monitoring Device Market by End-user
5.6 Italy Continuous Glucose Monitoring Device Market
5.6.1 Italy Continuous Glucose Monitoring Device Market by Component
5.6.2 Italy Continuous Glucose Monitoring Device Market by End-user
5.7 Rest of Europe Continuous Glucose Monitoring Device Market
5.7.1 Rest of Europe Continuous Glucose Monitoring Device Market by Component
5.7.2 Rest of Europe Continuous Glucose Monitoring Device Market by End-user
CHAPTER 6. COMPANY PROFILES
6.1 Abbott Laboratories
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 Medtronic PLC
6.2.1 Company overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Acquisition and Mergers:
6.2.5.3 Approvals:
6.3 F. Hoffmann-La Roche Ltd.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Novo Nordisk A/S
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental & Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Acquisition and Mergers:
6.5 DexCom, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expenses
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Approvals:
6.6 Ypsomed AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Senseonics Holdings, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 GlySens, Incorporated
6.8.1 Company Overview
6.8.2 Recent strategies and developments:
6.8.2.1 Approvals:
6.9 A. Menarini Diagnostics Ltd. (The Menarini Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.1 Echo Therapeutics, Inc.
6.10.1 Company Overview
6.11 Johnson and Johnson
6.11.1 Company Overview
6.11.2 Financial Analysis
6.11.3 Segmental &Regional Analysis
6.11.4 Research & Development Expenses
6.11.5 Recent strategies and developments:
6.11.5.1 Approvals:
LIST OF TABLES
TABLE 1 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE SENSORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE SENSORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE TRANSMITTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE TRANSMITTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE RECEIVERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE RECEIVERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 12 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 13 EUROPE HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE HOMECARE SETTINGS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE HOMECARE SETTINGS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 22 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 23 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 24 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 25 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 26 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 27 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 28 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 29 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 30 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 31 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 32 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 33 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 34 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 35 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 36 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 37 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 38 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 45 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 46 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 47 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 48 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 49 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 50 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 51 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 52 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 53 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 54 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 55 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 56 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 216 - 2019, USD MILLION
TABLE 62 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 64 KEY INFORMATION – MEDTRONIC PLC
TABLE 65 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 66 KEY INFORMATION – NOVO NORDISK A/S
TABLE 67 KEY INFORMATION – DEXCOM, INC.
TABLE 68 KEY INFORMATION –-YPSOMED AG
TABLE 69 KEY INFORMATION – SENSEONICS HOLDINGS, INC.
TABLE 70 KEY INFORMATION – GLYSENS, INCORPORATED
TABLE 71 KEY INFORMATION – A. MENARINI DIAGNOSTICS LTD.
TABLE 72 KEY INFORMATION – ECHO THERAPEUTICS, INC.
TABLE 73 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 1 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 2 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 3 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 4 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 5 EUROPE SENSORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 6 EUROPE SENSORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 7 EUROPE TRANSMITTERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 8 EUROPE TRANSMITTERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 9 EUROPE RECEIVERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 EUROPE RECEIVERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 12 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 13 EUROPE HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 EUROPE HOSPITALS CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 EUROPE HOMECARE SETTINGS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 EUROPE HOMECARE SETTINGS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 EUROPE OTHER END USERS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 EUROPE OTHER END USERS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 22 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 23 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 24 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 25 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 26 GERMANY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 27 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 28 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 29 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 30 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 31 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 32 UK CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 33 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 34 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 35 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 36 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 37 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 38 FRANCE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 39 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 40 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 41 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 42 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 43 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 44 RUSSIA CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 45 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 46 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 47 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 48 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 49 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 50 SPAIN CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 51 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 52 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 53 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 54 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 55 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2016 - 2019, USD MILLION
TABLE 56 ITALY CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 57 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2016 - 2019, USD MILLION
TABLE 58 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET, 2020 - 2026, USD MILLION
TABLE 59 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2016 - 2019, USD MILLION
TABLE 60 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY COMPONENT, 2020 - 2026, USD MILLION
TABLE 61 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 216 - 2019, USD MILLION
TABLE 62 REST OF EUROPE CONTINUOUS GLUCOSE MONITORING DEVICE MARKET BY END-USER, 2020 - 2026, USD MILLION
TABLE 63 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 64 KEY INFORMATION – MEDTRONIC PLC
TABLE 65 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 66 KEY INFORMATION – NOVO NORDISK A/S
TABLE 67 KEY INFORMATION – DEXCOM, INC.
TABLE 68 KEY INFORMATION –-YPSOMED AG
TABLE 69 KEY INFORMATION – SENSEONICS HOLDINGS, INC.
TABLE 70 KEY INFORMATION – GLYSENS, INCORPORATED
TABLE 71 KEY INFORMATION – A. MENARINI DIAGNOSTICS LTD.
TABLE 72 KEY INFORMATION – ECHO THERAPEUTICS, INC.
TABLE 73 KEY INFORMATION –JOHNSON AND JOHNSON
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 4 RECENT STRATEGIES AND DEVELOPMENTS: F. HOFFMANN-LA ROCHE LTD.
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: NOVO NORDISK A/S
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 RECENT STRATEGIES AND DEVELOPMENTS: ABBOTT LABORATORIES
FIG 3 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 4 RECENT STRATEGIES AND DEVELOPMENTS: F. HOFFMANN-LA ROCHE LTD.
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: NOVO NORDISK A/S
